Lorde Says MDMA Therapy Helped Cure Her Stage Fright
Lorde revealed that guided MDMA-assisted therapy helped her address deep-rooted stage fright that had been quietly shadowing her career.
Read More
From Crisis to Healing: Keta Medical Center’s Dr. Haviva Malina on Ketamine’s Potential
In this Q&A, we sit down with Dr. Haviva Malina, MD, a physician whose career bridges the critical fields of emergency medicine and mental health.
Read More
HealingMaps and Advanced Behavioral Strategies Launch Healing Health Alliance, the First Group Purchasing Organization (GPO) Exclusively for Ketamine, Psychedelic Medicine and TMS Clinics
HealingMaps and Advanced Behavioral Strategies (ABS) announced the official launch of the Healing Health Alliance.
Read More
5 Simple Ways Ketamine Clinics Can Save Money
We are helping the ketamine practitioners solve increased overhead costs, complex insurance requirements, and supply chain issues.
Read More
Single Psilocybin Dose Shows Lasting Relief for Depression in Cancer Patients
A single dose of psilocybin may offer lasting relief from depression in cancer patients according to a new study.
Read More
Introducing The Healing Health Alliance – The First GPO for the Ketamine Industry
We are launching the Healing Health Alliance -- the ketamine industry's first GPO -- which will save clinics up to 20% on medical supplies.
Read More
Colorado Governor Signs Bill Allowing Psychedelic Conviction Pardons
Colorado Governor Jared Polis has signed a new bill allowing people with past psychedelic drug convictions to apply for pardons.
Read More
2025 Ketamine Practitioner Intelligence Research Report
What are ketamine practitioner's biggest pain points? Our 2025 Ketamine Practitioner Intelligence Research Report breaks it down.
Read More
Historic: Texas Invests $50 Million into Ibogaine Research
Texas has taken a bold step in mental health research by allocating $50 million to fund clinical trials of ibogaine.
Read More
Positive Data Shows Promise of 5-MeO-DMT in Patients When Used With SSRIs
This trial marks a significant departure and may reshape how clinicians combine traditional antidepressants and psychedelic therapy.
Read More